Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 30.57M P/E - EPS this Y 54.50% Ern Qtrly Grth -
Income -60.34M Forward P/E -0.78 EPS next Y 30.90% 50D Avg Chg -46.00%
Sales - PEG 0.58 EPS past 5Y - 200D Avg Chg -51.00%
Dividend N/A Price/Book 1.08 EPS next 5Y -2.49% 52W High Chg -86.00%
Recommedations 1.70 Quick Ratio 5.08 Shares Outstanding 38.26M 52W Low Chg 13.00%
Insider Own 14.13% ROA -45.62% Shares Float 26.57M Beta 0.28
Inst Own 40.12% ROE -80.54% Shares Shorted/Prior 1.01M/1.23M Price 2.56
Gross Margin - Profit Margin - Avg. Volume 227,779 Target Price 11.38
Oper. Margin - Earnings Date Nov 11 Volume 573,327 Change 0.79%
About Leap Therapeutics, Inc.

Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops antibody therapies for the treatment of cancer. Its lead product candidates include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric and gynecologic cancers; and FL-301, a monoclonal antibody that targets cells that express Claudin18.2 on their cell surface and is in phase II clinical trial, as well as two preclinical antibody programs, FL-302 and FL-501. Leap Therapeutics, Inc. has an option and license agreement with NovaRock, Adimab, and BeiGene, Ltd. to develop and commercialize DKN-01 in Asia (excluding Japan), Australia, and New Zealand. The company was formerly known as HealthCare Pharmaceuticals, Inc. and changed its name to Leap Therapeutics, Inc. in November 2015. Leap Therapeutics, Inc. was incorporated in 2011 and is based in Cambridge, Massachusetts.

LPTX Chatroom

User Image Sharky72 Posted - 14 minutes from now

$LPTX I think we are close to the turningpoint.

User Image Bullly Posted - 57 minutes ago

$LPTX back to $2 ?

User Image Redboal Posted - 1 hour ago

$LPTX Proverbial wall at $2.60. comical watching the order flow and the ask size never changes

User Image Aurum81 Posted - 3 hours ago

$LPTX Interesting but also unattractive figures: 8 trading days LPTX went up from $2.33 to $4.79 and since then in the last 15 trading days 12 down to currently $2.59

User Image cavsnut Posted - 15 hours ago

$LPTX https://academic.oup.com/carcin/article/42/6/814/6211334 😉

User Image SuperCool5000 Posted - 21 hours ago

$LPTX Opportunity aside, I hate this stock. The idea of “manipulation” is way overused on ST, but @Redboal has the receipts. He could write a book… which I wouldn’t read, because it would just piss me off. Such a chronically undervalued piece of garbage. You would never know the company’s potential looking at the price. Let’s get to the data. Time to rip faces off.

User Image BMK00 Posted - 21 hours ago

$LPTX Could touch 2.40 before bounce up imo

User Image Walter100 Posted - 22 hours ago

$LPTX Thank you @Apr4609 😂

User Image beforethedeluge Posted - 22 hours ago

$LPTX faceplanting early today.

User Image Walter100 Posted - 22 hours ago

$LPTX Worth reading when an artificial price crashed to like this happens👇: https://stocktwits.com/Apr4609/message/592544252

User Image Aurum81 Posted - 23 hours ago

$LPTX https://youtu.be/9APAHhIPhJE?si=v25ZuWjxlBscwIyn

User Image deano361 Posted - 23 hours ago

$LPTX unexpected but opportunity for some. Seen this before . If data is good or great all The whiners will be out

User Image IwM Posted - 23 hours ago

$LPTX comical price ahead of data readout and “potential” of GDF15 assets following PFE validation. Buying down here. Things can change in an instant 👀 Would love Doug to provide updates in advance of Piper conf Dec 3-5. JPM conf in January

User Image Walter100 Posted - 23 hours ago

$LPTX Hilarious 😀😀

User Image LonePine1995 Posted - 23 hours ago

$LPTX nothing stopping this except data. Hope the company figures this out before we're back below 2.

User Image MadeMaid Posted - 1 day ago

$LPTX talk about getting left behind in the market melt up, you have this turd.

User Image Walter100 Posted - 1 day ago

$LPTX From Interactive Brokers👇. Looks like there’s a fair amount of shorting going on:

User Image BMK00 Posted - 1 day ago

$LPTX Good area to scoop up more

User Image cavsnut Posted - 1 day ago

$LPTX investing tidbit from @Foxesthrufences on X yesterday … (GDF-15 over expression possibly due to the affects of long term chemo ) So had me wondering a bit.. GDF-15/DKK1 both highly expressed in G/GEJ With the G/GEJ RCT results on the horizon anytime now, wonder why recent BeiGene 13g filing when unnecessary? My hypothesis… 50-60% of N develop resistance to 5FU (fluorourcil) over time , BeiGene’s capecitabine changes into 5FU naturally in the body High levels of DKK1 play an important role in fact in that 50-60% resistance, so… DKN-01 inhibits over expression of DKK1, BeiGene’s capecitabine increases 5FU naturally in the body, which increases 5FU expression, for reversal of resistance BeiGene’s chemo( capecitabine) , anti-PD-1 , Leap’s DKK1 targeted therapy may/may not exceed SOC G/GEJ, but I’m sure combined with an already RCT trial proven GDF-15 blockade (fl-501) it will, with a TAM in the billions…

User Image Walter100 Posted - 1 day ago

$LPTX https://stocktwits.com/jackofalltrade/message/593066546

User Image sebstothemoon Posted - 1 day ago

$LPTX bought another chunk today. 11k shares now averaged at $4.2. Original purchase was in ’21.

User Image BiodegradableShxt Posted - 1 day ago

$LPTX When will this stop sucking?

User Image Bates333 Posted - 1 day ago

$LPTX bought 200 shares let’s see what happens

User Image deano361 Posted - 2 days ago

$LPTX next move up is the good one . We must need to bounce up over $3 again

User Image lidopete Posted - 2 days ago

$LPTX (FL -501, gdf-15) Yes, according to recent financial filings, Gilead Sciences (GILD) is confirmed to be an investor in Leap Therapeutics (LPTX) stock, having participated in a private placement financing round for the company; meaning GILD holds a portion of LPTX shares.

User Image jackofalltrade Posted - 2 days ago

$LPTX Baird - We see a strong upside if the trial is successful (surpassing our $9 price target)

User Image jackofalltrade Posted - 2 days ago

@deano361 exactly. the report says as much. $LPTX

User Image jackofalltrade Posted - 2 days ago

$LPTX There is unmet need for I-O drugs in first-line gastric cancer. While PD-1 drug Keytruda has shown monotherapy efficacy in relapsed/refractory PD-(L)1+ gastric cancer, this has not translated into first-line treatment. As such, there is unmet need to expand the utility of I-O agents in first-line gastric cancer.

User Image jackofalltrade Posted - 2 days ago

Baird- We believe credit for DKN-01 in additional cancers beyond gastric/GEJ is missing from the stock price. The strong and consistent ph2a data in gastric/GEJ cancer suggests to us that there's a good probability that DKN-01 could provide a benefit in other cancers beyond gastric with high DKK1. Potential settings with some early supportive data include endometrial, colorectal, lung, and prostate. $LPTX

User Image jackofalltrade Posted - 3 days ago

$LPTX RWBaird reiterated buy while maintaining $9 price target.

Analyst Ratings
HC Wainwright & Co. Buy Aug 13, 24
Rodman & Renshaw Buy Jun 28, 24
HC Wainwright & Co. Buy May 14, 24
Baird Outperform Mar 19, 24
HC Wainwright & Co. Buy Mar 19, 24
Mizuho Buy Nov 20, 23
Raymond James Outperform Nov 14, 23
Baird Outperform Aug 15, 23
HC Wainwright & Co. Buy Aug 15, 23